In a striking reversal, federal regulators said that they would wait for data on whether three doses of Pfizer-BioNTech’s vaccine are effective in children younger than 5.
Author: Sharon LaFraniere and Noah Weiland
F.D.A. Fully Approves Pfizer-BioNTech’s Vaccine, a First for a Covid-19 Shot
The move was expected to kick off a round of new vaccination mandates from hospitals, schools and private companies.
F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Covid Vaccine
Federal regulators concluded that the risk of developing the syndrome was low, and that the benefits of the vaccine still strongly outweigh it.
Some Johnson & Johnson Covid Vaccine Doses Delayed in U.S. by Factory Mix-Up
A manufacturer in Baltimore accidentally conflated the ingredients for two different coronavirus shots, officials say.